Discovery and characterization of an antibody directed against exosite I of thrombin

Journal of Thrombosis and Haemostasis

Volumn 14, Issue 1, 2016, Pages 137-142

  Baglin, T P ^a   Langdown, J ^a   Frasson, R ^b   Huntington, J A ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Anticoagulants; Antithrombins; Blood coagulation; Crystallography; Paraproteins; Thrombin

Indexed keywords

D DIMER; FIBRINOGEN; GLIPIZIDE; IMMUNOGLOBULIN A; METFORMIN; THROMBIN; THROMBIN INHIBITOR; THROMBOPLASTIN; ANTICOAGULANT AGENT; ANTITHROMBIN; EPITOPE; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; IMMUNOGLOBULIN F(AB) FRAGMENT;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD CLOTTING TEST; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HEADACHE; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; HYSTERECTOMY; IN VITRO STUDY; KNEE SURGERY; MEDICAL EXAMINATION; MEDICAL HISTORY; MENORRHAGIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL THROMBOPLASTIN TIME; PATELLA DISLOCATION; PRIORITY JOURNAL; PROTHROMBIN TIME; SUBDURAL HEMATOMA; THROMBIN TIME; THROMBOCYTE AGGREGATION; UTERUS MYOMA; WEAKNESS; BLEEDING; BLOOD CLOTTING; CHEMISTRY; HEMOSTASIS; IMMUNOLOGY; PHENOTYPE;

ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; EPITOPES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMATOMA, SUBDURAL; HEMORRHAGE; HEMOSTASIS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN FAB FRAGMENTS; MIDDLE AGED; PHENOTYPE; THROMBIN;

EID: 84955191360     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13171     Document Type: Article

References (21)

1. Huntington J. Structural insights into the life history of thrombin. In: Tanaka K, Davie E, Ikeda Y, Iwanaga S, Saito H, Sueishi K, eds. Recent Advances in Thrombosis and Hemostasis 2008. Tokyo: Springer, 2008: 80-106.
2. Huntington JA, Baglin TP. Targeting thrombin-rational drug design from natural mechanisms. Trends Pharmacol Sci 2003; 24: 589-95.
3. Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood 2005; 106: 2605-12.
4. Arbit B, Hsu JC. Non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation and associated intracranial hemorrhage: a focused review. Clin Cardiol 2015; doi:10.1002/clc.22434.
5. Scully MF, Ellis V, Kakkar VV, Savidge GF, Williams YF, Sterndale H. An acquired coagulation inhibitor to factor II. Br J Haematol 1982; 50: 655-64.
6. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001; 233: 88-96.
7. Lechtenberg BC, Johnson DJ, Freund SM, Huntington JA. NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation. Proc Natl Acad Sci USA 2010; 107: 14087-92.
8. Abdiche Y, Malashock D, Pinkerton A, Pons J. Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. Anal Biochem 2008; 377: 209-17.
9. Leslie AW, Powell H. Processing diffraction data with mosflm. In: Read R, Sussman J, eds. Evolving Methods for Macromolecular Crystallography. Dordrecht: Springer, 2007: 41-51.
10. Evans PR. An introduction to data reduction: space-group determination, scaling and intensity statistics. Acta Crystallogr D Biol Crystallogr 2011; 67: 282-92.
11. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ. Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 2005; 61: 458-64.
12. Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai SP, Compaan DM, Yin J, Gong Q, Kelley RF, DeForge LE, Martin F, Starovasnik MA, Fuh G. Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 2006; 108: 3103-11.
13. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989; 8: 3467-75.
14. Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997; 53: 240-55.
15. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
16. Wu Q, Picard V, Aiach M, Sadler JE. Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody. J Biol Chem 1994; 269: 3725-30.
17. Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost 2005; 3: 1861-72.
18. Tang J, Ai J, Macdonald RL. Developing a model of chronic subdural hematoma. Acta Neurochir Suppl 2011; 111: 25-9.
19. Aspegren OP, Astrand R, Lundgren MI, Romner B. Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 2013; 115: 981-4.
20. De Bonis P, Trevisi G, de Waure C, Sferrazza A, Volpe M, Pompucci A, Anile C, Mangiola A. Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly. PLoS ONE 2013; 8: e68732.
21. Pechik I, Yakovlev S, Mosesson MW, Gilliland GL, Medved L. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. Biochemistry 2006; 45: 3588-97.